Skip to main content
OpenTrials
Completed

NCT Number: NCT05247372

The Effect of Iyengar Yoga Practice on Patients with Multiple Sclerosis

The aim of this work is to find out what effect the practice of Iyengar yoga has on patients with multiple sclerosis on the EDSS 5 and more, specifically in the field of mobility, self-sufficiency and anxiety.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS Autoimmune Diseases Autoimmune Diseases of the Nervous System Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Immune System Diseases Multiple Sclerosis Nervous System Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Motol

Prague, Czech Republic, 15006, Czechia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age over 18 years
  • diagnosis of multiple sclerosis
  • EDSS grade 5 or higher

Exclusion criteria

  • age less than 18 years
  • the patient is not diagnosed with multiple sclerosis EDSS grade less than 5
  • refusal of the subject to participate in the study

Treatment and study plan

The effect of Iyengar yoga practice on patients with multiple sclerosis

Other

The study will be conducted as a longitudinal follow-up - at first patients will fbe examined 2 months before the start of the exercise, than they will be examined at the beginning and end of the exercise, which they will attend for 3 months. Patients will be re-examined 2 months after the end of the exercise to clarify the continuing effect of the exercise. The examination will include a basic kinesiological analysis and a neurological examination,TUG test, 6MWT along with the Borg Subjective Weight Rating Scale and T25FWT, BBS, NHPT and stable sitting time in wheelchairs. To evaluate the development of the chest, the respiratory amplitude will be examined and the position of the spine in statics and dynamics will be evaluated using a spinal mouse. Quality of life will be assessed through the MFIS, MSIS-29, MSQOL 54 questionares and Beck's anxiety inventory.

Primary outcomes

  1. Hypothesis 1

    Time frame: 3 months

    Increase in respiratory amplitud. It will be measured by the meter.

  2. Hypothesis 2

    Time frame: 3 months

    Increase in spinal development in the sagittal and frontal plane. It will by measured by spinal mouse.

  3. Hypothesis 3

    Time frame: 3 months

    Increase in walking speed measured by T25FWT. It will by measured by stopwatch.

  4. Hypothesis 4

    Time frame: 3 months

    Balance improvement in the Berg balance scale. It will be measured by the Berg balance scale questionare.

  5. Hypothesis 5

    Time frame: 3 months

    The quality of life of patients with MS is improved subjectively evaluated through MSQOL54 questionare.

Sponsors and collaborators

Lead sponsor

University Hospital, Motol

Other

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Feb 18, 2022
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.